Latest Insider Transactions at Genworth Financial Inc (GNW)
This section provides a real-time view of insider transactions for Genworth Financial Inc (GNW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GENWORTH FINANCIAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GENWORTH FINANCIAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Jerome T Upton EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,277
-2.03%
|
$106,939
$7.3 P/Share
|
|
Feb 14
2025
|
Jerome T Upton EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,062
+7.0%
|
-
|
|
Feb 14
2025
|
Andrea Lynn White Pres. & CEO, CareScout Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
16,572
-1.32%
|
$116,004
$7.3 P/Share
|
|
Feb 14
2025
|
Andrea Lynn White Pres. & CEO, CareScout Ins. |
BUY
Exercise of conversion of derivative security
|
Direct |
52,756
+4.04%
|
-
|
|
Feb 14
2025
|
Jamala M. Arland Pres. & CEO, U.S. Life Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,875
-15.01%
|
$27,125
$7.3 P/Share
|
|
Feb 14
2025
|
Jamala M. Arland Pres. & CEO, U.S. Life Ins. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,946
+29.78%
|
-
|
|
Feb 14
2025
|
Melissa Hagerman EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,544
-8.88%
|
$115,808
$7.3 P/Share
|
|
Feb 14
2025
|
Melissa Hagerman EVP and Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
52,756
+21.95%
|
-
|
|
Feb 14
2025
|
Mark Blakeley Hodges EVP and Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,338
-9.3%
|
$86,366
$7.3 P/Share
|
|
Feb 14
2025
|
Mark Blakeley Hodges EVP and Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,352
+22.2%
|
-
|
|
Feb 14
2025
|
Gregory S. Karawan EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
14,641
-2.49%
|
$102,487
$7.3 P/Share
|
|
Feb 14
2025
|
Gregory S. Karawan EVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
52,756
+8.22%
|
-
|
|
Feb 14
2025
|
Kelly A Saltzgaber EVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,158
-16.24%
|
$43,106
$7.3 P/Share
|
|
Feb 14
2025
|
Kelly A Saltzgaber EVP & Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,891
+36.6%
|
-
|
|
Aug 26
2024
|
Thomas J Mc Inerney President and CEO; Director |
SELL
Open market or private sale
|
Direct |
150,000
-3.2%
|
$900,000
$6.88 P/Share
|
|
May 28
2024
|
Thomas J Mc Inerney President and CEO; Director |
SELL
Bona fide gift
|
Direct |
150,000
-3.44%
|
-
|
|
May 24
2024
|
Thomas J Mc Inerney President and CEO; Director |
SELL
Open market or private sale
|
Direct |
200,000
-4.38%
|
$1,200,000
$6.27 P/Share
|
|
May 23
2024
|
Ramsey D. Smith |
BUY
Grant, award, or other acquisition
|
Direct |
23,297
+31.48%
|
$139,782
$6.44 P/Share
|
|
May 23
2024
|
G Kent Conrad |
BUY
Grant, award, or other acquisition
|
Direct |
23,297
+31.48%
|
$139,782
$6.44 P/Share
|
|
May 23
2024
|
Karen Elizabeth Dyson |
BUY
Grant, award, or other acquisition
|
Direct |
23,297
+31.48%
|
$139,782
$6.44 P/Share
|
|
May 23
2024
|
Jill R Goodman |
BUY
Grant, award, or other acquisition
|
Direct |
23,297
+31.48%
|
$139,782
$6.44 P/Share
|
|
May 23
2024
|
Melina E Higgins |
BUY
Grant, award, or other acquisition
|
Direct |
41,935
+31.48%
|
$251,610
$6.44 P/Share
|
|
May 23
2024
|
Howard D. Mills Iii |
BUY
Grant, award, or other acquisition
|
Direct |
23,297
+31.48%
|
$139,782
$6.44 P/Share
|
|
May 23
2024
|
Robert P Restrepo Jr |
BUY
Grant, award, or other acquisition
|
Direct |
23,297
+18.79%
|
$139,782
$6.44 P/Share
|
|
May 23
2024
|
Elaine A Sarsynski |
BUY
Grant, award, or other acquisition
|
Direct |
41,935
+31.48%
|
$251,610
$6.44 P/Share
|
|
Mar 25
2024
|
Andrea Lynn White Pres. & CEO, CareScout Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
16,779
-2.76%
|
$100,674
$6.34 P/Share
|
|
Mar 25
2024
|
Andrea Lynn White Pres. & CEO, CareScout Ins. |
BUY
Exercise of conversion of derivative security
|
Direct |
37,203
+5.77%
|
-
|
|
Mar 25
2024
|
Jerome T Upton EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,318
-2.97%
|
$61,908
$6.34 P/Share
|
|
Mar 25
2024
|
Jerome T Upton EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,802
+6.67%
|
-
|
|
Mar 25
2024
|
Rohit Gupta President & CEO, Enact |
SELL
Payment of exercise price or tax liability
|
Direct |
46,327
-5.0%
|
$277,962
$6.34 P/Share
|
|
Mar 25
2024
|
Rohit Gupta President & CEO, Enact |
BUY
Exercise of conversion of derivative security
|
Direct |
105,407
+10.21%
|
-
|
|
Mar 25
2024
|
Gregory S. Karawan EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,831
-2.94%
|
$46,986
$6.34 P/Share
|
|
Mar 25
2024
|
Gregory S. Karawan EVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
17,362
+6.13%
|
-
|
|
Mar 01
2024
|
Rohit Gupta President & CEO, Enact |
SELL
Payment of exercise price or tax liability
|
Direct |
266,408
-24.48%
|
$1,598,448
$6.15 P/Share
|
|
Mar 01
2024
|
Rohit Gupta President & CEO, Enact |
BUY
Grant, award, or other acquisition
|
Direct |
606,160
+35.77%
|
-
|
|
Mar 01
2024
|
Gregory S. Karawan EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
45,028
-15.34%
|
$270,168
$6.15 P/Share
|
|
Mar 01
2024
|
Gregory S. Karawan EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
99,840
+25.38%
|
-
|
|
Mar 01
2024
|
Thomas J Mc Inerney President and CEO; Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,061,346
-18.87%
|
$6,368,076
$6.15 P/Share
|
|
Mar 01
2024
|
Thomas J Mc Inerney President and CEO; Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,353,316
+29.5%
|
-
|
|
Mar 01
2024
|
Jerome T Upton EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
62,685
-16.29%
|
$376,110
$6.15 P/Share
|
|
Mar 01
2024
|
Jerome T Upton EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
142,626
+27.04%
|
-
|
|
Mar 01
2024
|
Andrea Lynn White Pres. & CEO, CareScout Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
96,487
-14.47%
|
$578,922
$6.15 P/Share
|
|
Mar 01
2024
|
Andrea Lynn White Pres. & CEO, CareScout Ins. |
BUY
Grant, award, or other acquisition
|
Direct |
213,940
+24.29%
|
-
|
|
Feb 16
2024
|
Kelly A Saltzgaber EVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,386
-31.55%
|
$44,316
$6.19 P/Share
|
|
Feb 16
2024
|
Kelly A Saltzgaber EVP & Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,891
+48.32%
|
-
|
|
Feb 16
2024
|
Jerome T Upton EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,180
-3.15%
|
$91,080
$6.19 P/Share
|
|
Feb 16
2024
|
Jerome T Upton EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,061
+10.51%
|
-
|
|
Feb 16
2024
|
Andrea Lynn White Pres. & CEO, CareScout Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
16,674
-1.85%
|
$100,044
$6.19 P/Share
|
|
Feb 16
2024
|
Andrea Lynn White Pres. & CEO, CareScout Ins. |
BUY
Exercise of conversion of derivative security
|
Direct |
52,755
+5.51%
|
-
|
|
Feb 16
2024
|
Jamala M. Arland Pres. & CEO, U.S. Life Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,875
-20.68%
|
$23,250
$6.19 P/Share
|